A carregar...
Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
With the recent progress in imaging technologies for assessment of structural damage in glaucoma, a debate has emerged on whether these measurements can be used as valid surrogate endpoints in clinical trials evaluating new therapies for the disease. A discussion of surrogates should be grounded on...
Na minha lista:
| Publicado no: | Invest Ophthalmol Vis Sci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Association for Research in Vision and Ophthalmology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5455347/ https://ncbi.nlm.nih.gov/pubmed/28475699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.17-21987 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|